Potential molecular prognostic factors in nonsmall cell lung cancer patients treated with Gefitinib

被引：0
|
作者：
Polowy, CR [1 ]
Coon, J [1 ]
Qawi, H [1 ]
Villaflor, VM [1 ]
Leslie, W [1 ]
Lukic, I [1 ]
Kanevsky, G [1 ]
Gale, M [1 ]
Stewart, I [1 ]
Bonomi, P [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [41] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [42] SHOULD NONSMALL CELL-CARCINOMA OF THE LUNG BE TREATED WITH CHEMOTHERAPY - PRO - CHEMOTHERAPY IS FOR NONSMALL CELL LUNG-CANCER
    MASTERS, GA
    VOKES, EE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (05) : 1285 - 1287
  • [43] Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer
    Zhu, Xuee
    Liao, Chuanhong
    Penney, Bill C.
    Li, Feng
    Ferguson, Mark K.
    Simon, Cassie A.
    Wu, Tianming
    Liu, Haiyan
    Pu, Yonglin
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (02) : 185 - 192
  • [44] Clinical and prognostic significance of Merkel cell polyomavirus in nonsmall cell lung cancer
    Kim, Gun-Jik
    Lee, Jae-Ho
    Lee, Deok Heon
    MEDICINE, 2017, 96 (03)
  • [45] Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib
    Ando, M
    Okamoto, I
    Yamamoto, N
    Takeda, K
    Tamura, K
    Seto, T
    Ariyoshi, Y
    Fukuoka, M
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (16) : 2549 - 2556
  • [46] Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib
    Takano, T
    Ohe, Y
    Kusumoto, M
    Tateishi, U
    Yamamoto, S
    Nokihara, H
    Yamamoto, N
    Sekine, I
    Kunitoh, H
    Tamura, T
    Kodama, T
    Saijo, N
    LUNG CANCER, 2004, 45 (01) : 93 - 104
  • [47] Remarkable effect of gefitinib retreatment in a patient with nonsmall cell lung cancer who had a complete response to initial gefitinib
    Yoshimoto, Akihiro
    Inuzuka, Kanako
    Kita, Toshiyuki
    Kawashima, Atsuhiro
    Kasahara, Kazuo
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2007, 333 (04): : 221 - 225
  • [48] Practical management of patients with non-small-cell lung cancer treated with gefitinib
    Shah, NT
    Kris, MG
    Pao, W
    Tyson, LB
    Pizzo, BM
    Heinemann, MH
    Ben-Porat, L
    Sachs, DL
    Heelan, RT
    Miller, VA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 165 - 174
  • [49] SERUM-ALBUMIN AND OTHER PROGNOSTIC FACTORS RELATED TO RESPONSE AND SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
    ESPINOSA, E
    FELIU, J
    ZAMORA, P
    BARON, MG
    SANCHEZ, JJ
    ORDONEZ, A
    ESPINOSA, J
    LUNG CANCER, 1995, 12 (1-2) : 67 - 76
  • [50] The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy
    Ching-Yeh Hsiung
    Stephen Wan Leung
    Chong-Jong Wang
    Sing-Kai Lo
    Hui-Chun Chen
    Li-Min Sun
    Fu-Min Fang
    Journal of Neuro-Oncology, 1998, 36 : 71 - 77
12345